- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
24
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
24 companies
Madrigal Pharmaceuticals
Market Cap: US$11.7b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$514.12
7D
-6.0%
1Y
52.1%
Axsome Therapeutics
Market Cap: US$11.0b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$212.85
7D
-9.3%
1Y
104.0%
Corcept Therapeutics
Market Cap: US$11.9b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$110.69
7D
19.1%
1Y
57.0%
Alnylam Pharmaceuticals
Market Cap: US$30.6b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$228.72
7D
11.3%
1Y
-47.4%
Insmed
Market Cap: US$21.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$99.02
7D
-4.0%
1Y
-11.0%
BridgeBio Pharma
Market Cap: US$16.0b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$81.99
7D
-1.9%
1Y
83.0%
Royalty Pharma
Market Cap: US$33.1b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$57.75
7D
-2.4%
1Y
55.6%
Viatris
Market Cap: US$20.6b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$17.65
7D
-1.0%
1Y
101.7%
Ascendis Pharma
Market Cap: US$16.1b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$244.20
7D
-3.1%
1Y
n/a
Merck
Market Cap: US$316.1b
Operates as a healthcare company worldwide.
MRK
US$128.33
7D
-1.6%
1Y
61.5%
AbbVie
Market Cap: US$430.8b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$246.20
7D
-6.5%
1Y
25.4%
Teva Pharmaceutical Industries
Market Cap: US$40.1b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$34.72
7D
0.03%
1Y
116.9%
BeOne Medicines
Market Cap: US$35.9b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$327.53
7D
0.1%
1Y
9.7%
Gilead Sciences
Market Cap: US$167.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$131.76
7D
-0.7%
1Y
19.5%
Natera
Market Cap: US$39.3b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$274.62
7D
1.8%
1Y
94.7%
Biogen
Market Cap: US$30.8b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$206.63
7D
-1.2%
1Y
59.8%
Elanco Animal Health
Market Cap: US$12.8b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$26.22
7D
-0.6%
1Y
88.0%
Bio-Techne
Market Cap: US$11.2b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$72.00
7D
-0.04%
1Y
44.4%
Neurocrine Biosciences
Market Cap: US$16.9b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$161.50
7D
-10.7%
1Y
25.7%
Revvity
Market Cap: US$12.4b
Provides health sciences solutions, technologies, and services.
RVTY
US$115.02
7D
1.5%
1Y
33.9%
Waters
Market Cap: US$38.9b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$400.00
7D
5.4%
1Y
44.0%
ICON
Market Cap: US$12.1b
A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.
ICLR
US$163.51
7D
-8.2%
1Y
5.2%
BioMarin Pharmaceutical
Market Cap: US$11.7b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$59.91
7D
-2.4%
1Y
-1.3%
Charles River Laboratories International
Market Cap: US$11.3b
Charles River Laboratories International, Inc.
CRL
US$260.72
7D
11.0%
1Y
73.4%